China National Center for Cardiovascular Diseases: Atrial Fibrillation trials

The registry lists 23 Atrial Fibrillation studies with China National Center for Cardiovascular Diseases as lead sponsor. 17 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 3 1Phase 4 1No phase 20(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial FibrillationRecruitingNCT07877519Not applicable
• A Comparative Study of Percutaneous Pulsed Field Ablation Guided by Ultrasound Alone Versus Fluoroscopy in Patients With Atrial FibrillationNot yet recruitingNCT07762742Not applicable
• Unipolar Voltage Mapping for Personalized Atrial Fibrillation AblationRecruitingNCT07630857Not applicable
• Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)RecruitingNCT07601763Not applicable
• A Study of Using CARTO SOUND™ FAM to Guide Pulsed Field Ablation for Atrial FibrillationNot yet recruitingNCT07572253Not applicable
• pCAD-POAF 3 Year Follow-upRecruitingNCT07146061
• Precise Phenotyping Classification in Atrial FibrillationNot yet recruitingNCT07044011
• An Exploratory Clinical Study to Evaluate the Safety and Efficacy of a Cardiac Surgical Cryoablation System for the Treatment of Atrial FibrillationNot yet recruitingNCT06703528
• Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial FibrillationRecruitingNCT06615596Early Phase 1
• Consistency of LGE-MRI Fibrosis and EAM Low-voltage AreaRecruitingNCT06552845
• The Impact of Autonomic Function on Atrial Fibrillation Recurrence After Pulmonary Vein AblationRecruitingNCT06202209
• Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial FibrillationRecruitingNCT06108414Phase 4
• LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.RecruitingNCT06021808Not applicable
• Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic CardiomyopathyRecruitingNCT05610215Not applicable
• Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation RegistryRecruitingNCT05598632
• Bi-atrial Versus Left Atrial Ablation for Patients With Rheumatic Mitral Valve Disease and Non-paroxysmal Atrial FibrillationRecruitingNCT05021601Not applicable
• Effects of Left Atrial Appendage Resection and Marshall Ligament Amputation on Clinical Outcome in Patients Undergoing Off-pump Coronary Artery BypassRecruitingNCT04220047Not applicable
• Clinical Value of Linear Ablation Without Pulmonary Vein Isolation in Persistent Atrial FibrillationStatus unknownNCT05468528Not applicable
• A New Way of Cardiac Denervation to Reduce the Incidence of AF After CABG.CompletedNCT05009914Not applicable
• Genotype-guided Versus Standard for Warfarin DosingCompletedNCT03479684Not applicable
• Comparison Between One-stage Hybrid Ablation and Thoracoscopic Surgical Ablation for Intractable Atrial FibrillationCompletedNCT03127423Not applicable
• Catheter Ablation Therapy for Persistent Atrial FibrillationStatus unknownNCT02892162Not applicable
• Efficiency of Radiofrequency Ablation for Surgical Treatment of Chronic Atrial Fibrillation With Rheumatic Valve DiseaseStatus unknownNCT01013688Phase 3